Humana Inc. (NYSE:HUM) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure
meet with investors at various times between March 1, 2017 and
March 31, 2017. During such meetings, Humanas management expects
to reaffirm its guidance range of $16.65 to $16.85 in diluted
earnings per common share (EPS), and $10.80 to $11.00 in adjusted
EPS, in each case for the year ending December 31, 2017. This
guidance is consistent with the guidance issued in Humanas press
release dated February 14, 2017. The date and time of
presentations to investors are available via the Investor
Relations calendar of events on Humanas web site at
www.humana.com.
financial measure that is not in accordance with GAAP. Management
believes that this measure, when presented in conjunction with
the comparable measure of GAAP EPS, is useful to both management
and its investors in analyzing the Companys ongoing business and
operating performance. Consequently, management uses adjusted EPS
as an indicator of the Companys business performance, as well as
for operational planning and decision making purposes. Adjusted
EPS should be considered in addition to, but not as a substitute
for, or superior to, GAAP EPS. A reconciliation of adjusted EPS
to GAAP EPS follows:
|
Diluted earnings per common share
|
FY17 Guidance
|
|
GAAP
|
$16.65 to $16.85
|
|
Net (gain) expenses associated with the now-terminated
merger transaction (primarily the break-up fee) |
(~4.32)
|
|
Amortization of identifiable intangibles
|
~0.31
|
|
Beneficial effect of lower effective tax rate in light of
pricing and benefit design assumptions associated with the 2017 temporary suspension of the non-deductible health insurance industry fee; excludes Individual Commercial business impact |
(~2.14)
|
|
Estimated guaranty fund assessment expense to support the
policyholder obligations of Penn Treaty (an unaffiliated long-term care insurance company) |
~0.13
|
|
Operating losses associated with the Individual
Commercial business given the companys planned exit on January 1, 2018 |
~0.17
|
|
Adjusted (non-GAAP) FY17 projected
|
$10.80 – $11.00
|
About Humana Inc. (NYSE:HUM)
Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only products. The Healthcare Services segment includes services, such as pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies. Humana Inc. (NYSE:HUM) Recent Trading Information
Humana Inc. (NYSE:HUM) closed its last trading session up +2.06 at 213.38 with 1,820,587 shares trading hands.
